Engineered Type IV Pilin of Clostridium Difficile
The present invention relates to engineered Clostridium difficile type IV pilin (tfp) genes, type IV pilin proteins which can serve as a diagnostic marker for identification of patients infected with C. difficile, and vaccines comprising type IV pilin proteins, antigenic fragments and variants thereof for therapeutic interventions.
WO 2,010,135,585 [MORE INFO
DONNENBERG MICHAEL [US]
Type of Offer:
« More Biotech Patents